Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-02-28

Clinical Trial Update: Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intravenous iron in hospitalized patients with severe heart failure without iron deficiency has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous iron

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Heart Failure | Phase 4 | Status: WITHDRAWN